Philippe Guedat

USPTO Granted Patents = 13 (Patent Applications = 6)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 10)

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 14(Granted Patents)

Location History:

Toussieu, FR (2010)
Montenois, FR (2008 - 2021)

Company Filing History:

United Kingdom Research and Innovation

Medical Research Council

patents

where one patent can have more than one assignee

Years Active: 2008-2021

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11084783 - O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated with an accumulation of misfolded proteins (2021-08-10),

2. 10954198 - Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases (2021-03-23),

3. 10709677 - Therapeutic uses of benzylideneguanidine derivatives for the treatment of proteopathies (2020-07-14),

4. 10675257 - Method of treating cancer with a combination of benzylideneguanidine derivatives and chemotherapeutic agent (2020-06-09),

5. 10544093 - O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated an accumulation of misfolded proteins (2020-01-28),

6. 10526297 - Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases (2020-01-07),

7. 10100020 - Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases (2018-10-16),

8. 9682943 - Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases (2017-06-20),

9. 8648076 - Cysteine protease inhibitors and their therapeutic applications (2014-02-11),

10. 7875613 - Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications (2011-01-25),

11. 7767819 - Thiazolylimidazole derivatives and their use as inhibitors of microsomal triglyceride transfer protein (2010-08-03),

12. 7723358 - Aroyl-O-piperidine derivatives for the treatment of diabetes-related problems (2010-05-25),

13. 7462615 - Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications (2008-12-09),

Title: **Philippe Guedat: Innovator in Protein Misfolding Treatment**

Introduction

Philippe Guedat is a notable inventor based in Montenois, France, recognized for his significant contributions to the field of medicinal chemistry. With a total of 13 patents to his name, Philippe is at the forefront of developing innovative compounds aimed at addressing critical health issues, particularly those related to misfolded proteins.

Latest Patents

Philippe's latest patents include groundbreaking work on O-alkyl-benzylideneguanidine derivatives. This invention involves a compound designed for the therapeutic treatment of disorders associated with the accumulation of misfolded proteins, also known as protein misfolding stress. The patent details the formulation of the compound, which includes variations such as tautomers and pharmaceutically acceptable salts.

Another significant patent focuses on benzylideneguanidine derivatives for treating protein misfolding diseases. His innovative compounds are characterized by specific structural formulas targeting various disorders linked to protein misfolding, indicating their potential utility in developing new therapeutic strategies.

Career Highlights

Throughout his career, Philippe has been associated with prominent organizations, including Inflectis Bioscience and UK Research and Innovation. His work at these institutions underlines his commitment to advancing scientific research and creating impactful health solutions. Innovative ideas and a dedication to research have consistently marked his professional journey.

Collaborations

Philippe has collaborated with distinguished professionals in the field, including Anne Bertolotti and Frédéric Colland. These partnerships have facilitated the exchange of knowledge and expertise, further contributing to the advancement of research focused on tackling protein misfolding disorders.

Conclusion

Philippe Guedat stands out as a prolific inventor whose work addressing protein misfolding has the potential to revolutionize treatment approaches in medicine. With an impressive array of patents and fruitful collaborations, Philippe continues to drive innovation in the health sciences, making significant strides toward effective therapies for complex diseases.

This text is generated by artificial intelligence and may not be accurate.